Fitness of Japanese encephalitis virus to neuro-2a cells is determined by interactions of the viral envelope protein with highly sulfated glycosaminoglycans on the cell surface

Journal of Medical Virology

Volumn 76, Issue 4, 2005, Pages 583-592

  Chiou, Shyan Song ^a,b   Liu, Hsuan ^c,d   Chuang, Ching Kai ^a   Lin, Chiou Chun ^a   Chen, Wei June ^a,e  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Envelope; Glycosaminoglycans (GAGS); Japanese encephalitis virus; Mutation; Neuro 2a cells

Indexed keywords

AMINO ACID; ASPARAGINE; ASPARTIC ACID; GLYCOSAMINOGLYCAN; LYSINE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CARBOHYDRATE INTERACTION; VIRUS INFECTION; VIRUS MUTATION; VIRUS PLAQUE; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CRICETINAE; DNA MUTATIONAL ANALYSIS; ENCEPHALITIS VIRUS, JAPANESE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; MICE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURONS; PLAQUE ASSAY; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

JAPANESE ENCEPHALITIS VIRUS; MAMMALIA;

EID: 21744440122     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20406     Document Type: Article

References (37)

1. Chambers TJ, Hahn CS, Galler R, Rice CM. 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44: 649-688.
2. Chen WJ, Dong CF, Chiou LY, Chuang WL. 2000. Potential role of Armigeres subalbatus (Diptera: Culicidae) in the transmission of Japanese encephalitis virus in the absence of rice culture on Liu-Chiu islet, Taiwan. J Med Entomol 37:108-113.
3. Chiou SS, Chen WJ. 2001. Mutations in the NS3 gene and 3′-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus. Virology 289:129-136.
4. Cooper LA, Scott TW. 2001. Differential evolution of Eastern Equine Encephalitis virus populations in response to host cell type. Genetics 157:1403-1412.
5. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74:7814-7823.
6. Dockter J, Evans CF, Tishon A, Oldstone MBA. 1996. Competitive selection in vivo by a cell for one variant over another: Implications for RNA virus quasispecies in vivo. J Virol 70:1799-1803.
7. Domingo E. 1992. Genetic variation and quasi-species. Curr Opin Genet Dev 2:61-63.
8. Domingo E, Escarmis C, Sevilla N, Moya A, Ellena SF, Quer J, Novella IS, Holland JJ. 1996. Basic concepts in RNA virus evolution. FASEB J 10:859-864.
9. Dropulic LK, Hardwick JM, Griffin DE. 1997. A single amino acid change in the E2 glycoprotein of Sindbis virus confers neurovirulence by altering an early step of virus replication. J Virol 71:6100-6105.
10. Germi R, Crance JM, Garin D, Guimet J, Lortat-Jacob H, Ruigrok RW, Zarski JP, Drouet E. 2002. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292:162-168 .
11. Gorman OT, Bean WJ, Webster RG. 1992. Evolutionary processes in influenza viruses: divergence, rapid evolution, and stasis. Curr Top Microbiol Immunol 176:75-97.
12. Holland JJ, De La Torre JC, Steinhauer DA. 1992. RNA virus population as quasispecies. Curr Top Microbiol Immunol 176:1-20.
13. Kirn CW, Goldberger OA, Gallo RL, Bernfield M. 1994. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 5:797-805.
14. Kjellen L, Lindahl U. 1991. Proteoglycans: Structures and interactions. Annu Rev Biochem 60:443-475.
15. Klimstra WB, Ryman KD, Johnston RE. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 72:7357-7366.
16. Lee E, Lobigs M. 2000. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol 74:8867-8875.
17. Lee E, Lobigs M. 2002. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76:4901-4911.
18. Lee E, Hall RA, Lobigs M. 2004. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses: J Virol 78:8271-8280.
19. Lindenbach BD, Rice CM. 2001. Flaviviridae: The viruses and their replication, In: Knipe DM, Howley PM. Editors. Fields virology, Vol. 1. 4th ed, Philadelphia: Lippincott Williams & Wilkins Publishers. pp 991-1041.
20. Liu H, Chiou SS, Chen WJ. 2004. Differential binding efficiency between the envelope protein of Japanese encephalitis virus variants with heparan sulfate on the cell surface. J Med Virol 72:618-624.
21. Lobigs M, Usha R, Nestorowicz A, Marshall ID, Weir RC, Dalgarno L. 1990. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 176:587-595.
22. Mandl CW, Kroschewski H, Allison SL, Kofler R, Holzmann H, Meixner T, Heinz FX. 2001. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate bindings sites in the envelope protein and attenuation in vivo. J Virol 75:5627-5637.
23. McMinn PC. 1997. The molecular basis of virulence of the encephalitogenic Flaviviruses. J Gen Virol 78:2711-2722.
24. Ni H, Barrett AD. 1998. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. Virology 241:30-36.
25. Raman R, Venkataraman G, Ernst S, Sasisekharan V, Sasisekharan R. 2003. Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Nat Acad Sci USA 100:2357-2362.
26. Rostand KS, Esko JD. 1997. Microbial adherence to and invasion through proteoglycans. Infect Immu 65:1-8.
27. Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 71:5115-5123.
28. Sawitzky D. 1996. Protein-glycosaminoglycan interactions: Infectiological aspects. Med Microbiol Immunol 184:155-161.
29. Schneider-Schaulies J. 2000. Cellular receptor for viruses: Links to tropism and pathogenesis. J Gen Virol 81:1413-1429.
30. Smit JM, Waarts BL, Kimata K, Klimstra WB, Bittman R, Wilschut J. 2002. Adaptation of alphaviruses to heparan sulfate: Interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J Virol 76:10128-10137.
31. Su CM, Liao CL, Lee YL, Lin YL. 2001. Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286:206-215.
32. Toida T, Yoshida H, Toyoda H, Koshiishi I, Imanari T, Hileman RE, Fromm JR, Linhardt RJ. 1997. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem J 322:499-506.
33. Vaughn DW, Hoke CH, Jr. 1992. The epidemiology of Japanese encephalitis: Prospects for prevention. Epidemiol Rev 14:197-221.
34. Wadstrom T, Ljungh A. 1999. Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: Key events in microbial pathogenicity. J Med Microbiol 48:223-233.
35. Wang WK, Lin SR, Lee CM, King CC, Chang SC. 2002. Dengue type 3 virus in plasma is a population of closely related genomes: Quasispecies. J Virol 76:4662-4665.
36. Wu SC, Lian WC, Hsu LC, Liau MY. 1997. Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res 51:173-181.
37. Yasui K. 2002. Neuropathogenesis of Japanese encephalitis virus. J Neuro Virol 8:112-114.